Work

Sirolimus, Tacrolimus and Reduced-Dose Methotrexate as Graft Versus Host Disease (GVHD)Prophylaxis after Non-Myeloablative Stem Cell Transplantation: Low Incidence of Acute GVHD Compared with Tacrolimus/Methotrexate or Cyclosporine/Prednisone.

Year: 2004

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v104.11.730.730

Authors: Edwin P. Alyea, Shuli Li, Haesook Kim, Corey Cutler, Vincent Ho, Stephanie J. Lee, John Gribben, Jerome Ritz, David C. Fisher, Robert J. Soiffer, Joseph H. Antin

Institutions: Brigham and Women's Hospital, Dana-Farber Cancer Institute

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2562731863

FWCI: 0.189

Cites:

Cited by: 5

Related to: 10